International Journal of Pharmaceutical Investigation logo

International Journal of Pharmaceutical Investigation · Archive

Volumes & Issues

Open a volume to see its issues, then pick an issue for its cover art and complete table of contents.

Keyboard: use Up/Down arrows to move between volumes, Home/End to jump to the first or last, and Enter to open or close a volume.

In this issue

41–48 of 48

Original Article(continued)

  1. Original ArticlePublished: 11 Jun 2026

    Vijay Sharma, Maneesh Kumar Singh, Gurvinder Pal Singh, Gyanendra Kumar Sharma, Navneet Verma

    pp. 1123-1134 · DOI: 10.5530/ijpi.20260567Vol. 16, Issue 3 (2026)

    Aim/Background: The aim of the present study was to develop and optimize a dosage form of L-arginine as a nanoparticle for prolonged release. The Quality by Design (QbD) approach was employed to develop and optimize the …

  2. Original ArticlePublished: 11 Jun 2026

    Sreeraj Kandoth, Narayana Charyulu Rompicherla, Sarath Chandran Chadrashekar Shenoy, Uday Venkat Mateti, Juno Jerold Joel, Sarin Shyamala Mohanan

    pp. 1135-1142 · DOI: 10.5530/ijpi.20260205Vol. 16, Issue 3 (2026)

    Background: Topical Corticosteroids (TCs) are widely prescribed for managing dermatological conditions due to their efficacy in reducing inflammation and related symptoms. However, misuse, suboptimal prescribing practice…

  3. Original ArticlePublished: 11 Jun 2026

    Ghadeer Bukhari

    pp. 1143-1151 · DOI: 10.5530/ijpi.20260265Vol. 16, Issue 3 (2026)

    Background: The NS5 protein in Dengue Virus Serotype-1 (DENV-1) is a multifunctional enzyme that is crucial for the virus to reproduce and evade the immune system. One important part of NS5 is the methyltransferase (MTas…

  4. Original ArticlePublished: 11 Jun 2026

    Rametrika Saha, Veeranagoud Biradar, Spoorti Konkani, Mandati Santhosh Reddy, Bhavana Doshi

    pp. 1152-1157 · DOI: 10.5530/ijpi.20260228Vol. 16, Issue 3 (2026)

    Background: Pemphigus vulgaris (PV) is a severe autoimmune blistering disorder traditionally managed with corticosteroids, which are associated with significant adverse effects; as a result, alternative therapies such as…

  5. Original ArticlePublished: 11 Jun 2026

    Mandati Santhosh Reddy, Madiwalayya Shivakantayya Ganachari

    pp. 1170-1175 · DOI: 10.5530/ijpi.20260262Vol. 16, Issue 3 (2026)

    Background: Antiplatelet therapy is central to managing Coronary Artery Disease (CAD), but benefits are offset by Adverse Drug Reactions (ADRs), particularly bleeding. Objectives: To compare the causality, severity, and …

  6. Original ArticlePublished: 11 Jun 2026

    Nawal Helmi, Hanadi Mohammed Baeissa, Israa Jameel Hakeem, Dalia Muhammed Alammari

    pp. 1176-1182 · DOI: 10.5530/ijpi.20260009Vol. 16, Issue 3 (2026)

    Background: High-touch surfaces in healthcare settings can act as reservoirs for microbial transmission, underscoring the need for durable antimicrobial surface interventions that remain effective under realistic use con…

  7. Original ArticlePublished: 11 Jun 2026

    Israa Jameel Hakeem, Shahnaz Haque, Misbahuddin Rafeeq, Mohammad Azhar Kamal, Tahani Bakhsh, Abdulrahman Almutairi, Rashed Ahmed Alniwaider, Ali Bin Thani, Qamre Alam

    pp. 1183-1193 · DOI: 10.5530/ijpi.20260022Vol. 16, Issue 3 (2026)

    Background: Cyclin-Dependent Kinase is a member of cell cycle regulatory proteins and active in the formation of tumor in breast. Three active compounds Anthraquinone, Emodin and Kaempferol are evaluated using DFT calcul…

Symposium Report

  1. Symposium ReportPublished: 11 Jun 2026

    Pitchai Balakumar, Murugan Thangiah, Saravanan Pandiaraj, Shubhada Nagarkar, P. Ilangovan, P.K. Srividhya, R. Malliga, V. Ramachandran, V. Anburaj, Gowraganahalli Jagadeesh

    pp. 1194-1201 · DOI: 10.5530/ijpi.20260003Vol. 16, Issue 3 (2026)

    It is imperative to address the complexities of conducting and disseminating high-quality research amidst a rapidly changing scientific environment in the era of Artificial Intelligence (AI). Despite the existence of ext…